A Randomized Controlled Trial Comparing Fat-free Versus Balanced (WHO) Diet in Gallstone Disease
NCT ID: NCT06405906
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
242 participants
INTERVENTIONAL
2024-03-27
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Is balanced WHO diet as good as low-fat diet in terms of patient reported outcomes when gallstone disease is managed non-operatively (RADIGAL-1) or cholecystectomy is performed (RADIGAL-2)?
A validated QoL questionnaire (Gastrointestinal Quality of Life Index - GIQLI) will be administered both at baseline and during follow-up. Analysis of covariance with ordinary least squares estimation will be applied to estimate between-group differences in GIQLI scores at 3 months (primary endpoint). Patient adherence and the disease-related symptoms occurrence or hospitalizations will also be appraised (secondary endpoint).
Participants presenting with biliary colic or acute cholecystitis (RADIGAL-1) or undergoing cholecystectomy for gallstones (RADIGAL-2) will:
* be randomly assigned to recommending either a fat-free or a balanced WHO diet .
* be contacted via phone call to complete the GIQLI questionnaire and document overall adherence to the diets and secondary outcome events.
This trial examines the impact of diet on adverse events in gallstone disease, representing the first randomized study to focus on this aspect.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial
NCT03875690
The Optimal Measurement Time for the New Gallbladder Function Assessment Method
NCT07321431
Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone
NCT06397430
Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass Surgery
NCT03585413
Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer
NCT02041871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biliary Colic Group - Non-operative Treatment - RADIGAL1
Patients presenting with biliary colic and treated non-operatively will be randomly assigned to receive fat-free diet or balanced WHO diet for 3 months.
Fat-free diet
The low-fat diet will consist of instructions to avoid fatty foods.
Balanced WHO diet
The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Cholecystitis Group - Non-operative Treatment - RADIGAL1
Patients presenting with acute cholecystitis and treated non-operatively will be randomly assigned to receive fat-free diet or balanced WHO diet for 3 months.
Fat-free diet
The low-fat diet will consist of instructions to avoid fatty foods.
Balanced WHO diet
The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Biliary Colic Group - Cholecystectomy - RADIGAL2
Patients undergoing cholecystectomy due to biliary colic will be randomly assigned to receive fat-free diet or balanced diet for 3 months.
Fat-free diet
The low-fat diet will consist of instructions to avoid fatty foods.
Balanced WHO diet
The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Cholecystitis Group - Cholecystectomy - RADIGAL2
Patients undergoing cholecystectomy due to acute cholecystitis will be randomly assigned to receive fat-free diet or balanced diet for 3 months.
Fat-free diet
The low-fat diet will consist of instructions to avoid fatty foods.
Balanced WHO diet
The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fat-free diet
The low-fat diet will consist of instructions to avoid fatty foods.
Balanced WHO diet
The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presenting with biliary colic in the ED or outpatient clinic, with the surgical team deciding to proceed with non-operative treatment (Group 1)
* presenting with acute calculous cholecystitis in the ED, with the surgical team deciding to proceed with non-operative management (Group 2)
* 18 years old or older
* undergoing uncomplicated cholecystectomy (open or laparoscopic without bile duct exploration) due to a history of biliary colic (Group 1)
* undergoing uncomplicated cholecystectomy (open or laparoscopic without bile duct exploration) due to acute cholecystitis (Group 2)
Exclusion Criteria
* inability to provide informed consent
* unwillingness to adhere to the recommended diet
* food allergies or intolerances that would prevent following the diet
* dietary habits (e.g., vegetarians, vegans) that preclude adherence to the recommended diet
* gallstone related cholangitis without biliary colic or cholecystitis
* complications from acute pancreatitis, such as pseudocysts, walled off necrosis, among others
* history of gastrointestinal disease which might affect diet, e.g., inflammatory bowel disease, irritable bowel syndrome, short bowel syndrome
* inability to provide informed consent
* unwillingness to adhere to the recommended diet
* food allergies or intolerances that would prevent following the diet - dietary habits (e.g., vegetarians, vegans) that preclude adherence to the recommended diet
* gallstone related cholangitis without biliary colic or cholecystitis
* complications from acute pancreatitis, such as pseudocysts, walled off necrosis, among others
* choledocholithiasis
* complicated cholecystectomy
* patients undergoing subtotal cholecystectomy
* whether primary operation differs from cholecystectomy (e.g., colectomy)
* patients having treated with percutaneous cholecystostomy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Crete
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Konstantinos Lasithiotakis
Assistant Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Konstantinos Lasithiotakis, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery, University Hospital of Heraklion
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery, University Hospital of Heraklion
Heraklion, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5414/27-03-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.